AVEO - AVEO Pharmaceuticals Inc's (AVEO) CEO Michael Bailey on Q4 2021 Results - Earnings Call Transcript

AVEO Pharmaceuticals, Inc. (AVEO) Q4 2021 Earnings Conference Call March 14, 2022 8:30 AM ET Company Participants Hans Vitzthum – LifeSci Advisors Michael Bailey – Chief Executive Officer Mike Ferraresso – Chief Commercial Officer Erick Lucera – Chief Financial Officer Conference Call Participants Stephen Willey – Stifel Swayampakula Ramakanth – H.C. Wainwright Colleen Kusy – Baird Soumit Roy – Jones Research Andrew Berens – SVB Leerink Presentation Operator Hello and welcome to the AVEO Oncology Fourth Quarter and Full Year 2021 Financial Results and 2022 Guidance Conference Call. At this time, all participants are in listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It's now my pleasure to turn the call over to Hans Vitzthum of LifeSci Advisors. Hans, please go ahead. Hans Vitzthum Thank you, operator. Good afternoon and thank you all for joining us on today's

For further details see:

AVEO Pharmaceuticals Inc's (AVEO) CEO Michael Bailey on Q4 2021 Results - Earnings Call Transcript